What Human Breast Milk Provides That Formula Cannot
Human breast milk is not simply a source of calories and macronutrients — it is a living biological fluid containing hundreds of bioactive components that protect and mature the premature gut. These include secretory IgA (the primary immune antibody in mucosal defense), lactoferrin (an iron-binding protein with antimicrobial and anti-inflammatory properties), lysozyme (a bacterial cell wall enzyme), human milk oligosaccharides (HMOs, which selectively feed beneficial bacteria and block pathogen adherence), epidermal growth factor (EGF) and insulin-like growth factor (IGF-1) (which promote intestinal healing and maturation), and exosomes and microRNA that regulate gene expression in the neonatal gut epithelium. Cow's milk-based premature infant formula provides none of these elements. It replaces a biologically complex, protective fluid with a nutritionally adequate but immunologically inert product that actively promotes different bacterial communities than human milk.
The AAP Position on Donor Breast Milk
The American Academy of Pediatrics (AAP) Section on Breastfeeding issued policy statements in 2012 and again in 2022 explicitly recommending pasteurized donor human milk as the preferred alternative to mother's own milk for premature infants when mother's milk is unavailable or insufficient. The 2022 AAP policy statement states: 'When the mother's own milk is unavailable or insufficient, pasteurized donor human milk should be used for preterm or high-risk infants.' The World Health Organization similarly recommends pasteurized donor breast milk as the second choice after mother's own milk for premature and sick newborns. The Human Milk Banking Association of North America (HMBANA) operates a network of non-profit donor milk banks across the US that screen, pasteurize, and dispense donor milk to NICUs. Despite the availability of donor milk through HMBANA and for-profit sources like Prolacta Bioscience and Medolac, many NICUs defaulted to cow's milk-based formula for economic or logistical reasons, while Abbott and Mead Johnson continued to market their bovine formula products without prominent warnings about the NEC risk.
The Legal Significance of the Breast Milk Evidence
The AAP's recommendation of donor breast milk over cow's milk formula for premature infants is among the most important pieces of evidence in NEC formula litigation. It establishes that a safer alternative existed and was endorsed by the nation's leading pediatric medical authority. It demonstrates that Abbott and Mead Johnson were marketing their products in the face of a clear professional medical consensus recommending against cow's milk formula as the preferred nutritional source for premature infants. Plaintiffs' experts use this evidence to argue that the defendants' warnings — such as they were — failed to communicate the scientific consensus adequately to the neonatologists, hospital formulary committees, and parents who made feeding decisions for premature infants.
Frequently Asked Questions
Related Pages
NEC Disease Overview: Stages, Symptoms, and What Happens in the NICU
Necrotizing Enterocolitis is a staged disease. Early detection (Stage I) allows medical management; advanced NEC (Stage III) requires emergency bowel surgery with a mortality rate of 20-30%. Understanding the stages, warning signs, and typical NICU progression is essential for families trying to understand what happened to their baby and whether they have a legal claim.
NEC Evidence and Records: What to Gather and Why It Matters
Building a successful NEC formula case requires three categories of records: (1) NICU feeding logs documenting formula product and volume; (2) diagnostic records confirming the NEC diagnosis; and (3) long-term medical records documenting the lasting harm. You do not need these records before contacting an attorney — your attorney can obtain them for you — but understanding what is needed helps families gather and preserve evidence.
NEC Statute of Limitations: State-by-State Deadlines and Minor Tolling Rules
The statute of limitations for NEC formula cases is among the most nuanced in all of mass tort law. Most states toll the SOL for personal injury claims belonging to minor children until the child turns 18 — meaning surviving NEC children often have claims that will not expire for many years. Parents filing their own claims (wrongful death or loss of consortium) face shorter deadlines. Do not assume your claim is time-barred without consulting a NEC attorney.
NEC Formula Settlements and Verdicts: What Cases Have Resolved and For How Much
NEC formula cases have produced some of the most significant verdicts in the history of mass tort litigation, with individual jury awards ranging from $1.5 million to $495 million. MDL bellwether trials are actively shaping settlement values in 2025-2026. Understanding the landscape of resolved cases helps families calibrate the potential value of their own claims.
Similac NEC Lawsuit: Abbott Laboratories and Similac Special Care Formula
Abbott Laboratories manufactures Similac Special Care — the most widely used cow's milk-based premature infant formula in the United States. Abbott has faced thousands of NEC lawsuits across state and federal courts, with bellwether verdicts in MDL 3026 producing nine-figure jury awards. Families whose premature infants developed NEC after receiving Similac in the NICU may have viable product liability claims against Abbott.
Enfamil NEC Lawsuit: Mead Johnson/Reckitt and Enfamil Premature Formula
Mead Johnson Nutrition — now owned by the British consumer goods giant Reckitt — manufactures Enfamil Premature, a cow's milk-based premature infant formula widely used in NICUs. Mead Johnson has faced some of the largest NEC jury verdicts in history, including a $495 million verdict in Missouri and a $60 million verdict in Illinois. Families whose premature infants received Enfamil in the NICU should contact a NEC attorney immediately.
Why Premature Infants Are Uniquely Vulnerable to NEC
The extreme vulnerability of premature infants to NEC is not an unfortunate coincidence — it is a biological certainty rooted in the profound immaturity of the preterm gut. Understanding why preterm infants are uniquely at risk helps families understand both the medical reality of what happened to their baby and why the NEC risk associated with cow's milk formula should have been disclosed more clearly.
NEC MDL 3026 in the Northern District of Illinois: What Families Need to Know
MDL No. 3026 — In Re: Abbott Laboratories, et al., Preterm Infant Formula Products Liability Litigation — is pending before Chief Judge Rebecca R. Pallmeyer in the United States District Court for the Northern District of Illinois. Understanding how the MDL works, what the bellwether trial program has produced, and how your individual case fits into the larger litigation is essential for families considering filing a NEC formula claim.
NEC Wrongful Death Claims: When a Premature Baby Does Not Survive
Losing a premature baby to NEC is an unimaginable tragedy. Families who lost their infants after NEC developed following formula feeding in the NICU may have wrongful death claims against Abbott and Mead Johnson. These cases carry some of the highest verdicts in the NEC litigation — including nine-figure jury awards — because juries respond powerfully to the preventable death of a premature baby.
NEC Long-Term Disabilities: Short Bowel Syndrome, TPN, and Neurodevelopmental Harm
Surviving NEC is only the beginning of a long medical journey for many premature infants. Short Bowel Syndrome, TPN dependency, intestinal failure-associated liver disease, and neurodevelopmental disabilities including cerebral palsy and cognitive impairment are common long-term sequelae of NEC. These lifelong medical needs dramatically increase the damages available in surviving-infant NEC claims.
NEC Hospital Liability: Can the NICU or Hospital Also Be Held Responsible?
In addition to product liability claims against Abbott and Mead Johnson, some NEC families may have medical malpractice claims against the hospital or NICU if the medical team deviated from the standard of care by failing to follow evidence-based breast milk guidelines, failing to inform parents of the NEC risk of formula, or failing to timely diagnose and treat NEC once it developed.
NEC Baby Formula (Similac/Enfamil) Lawsuit
Necrotizing Enterocolitis is one of the most catastrophic diseases affecting premature infants in the United States, striking approximately 12% of very-low-birthweight babies and carrying a mortality rate of 20-30%. Medical research spanning more than two decades has consistently linked cow's milk-based premature infant formula — particularly Similac Special Care (Abbott Laboratories) and Enfamil Premature (Mead Johnson/Reckitt) — to dramatically elevated NEC risk in preterm infants. Studies show that premature infants fed cow's milk-based formula are three to ten times more likely to develop NEC than those fed human breast milk or pasteurized donor breast milk. Despite this well-established scientific evidence and the recommendations of the American Academy of Pediatrics, Abbott and Mead Johnson continued to aggressively market their formula products to NICUs for use in the most vulnerable patient population in medicine. Thousands of families across the country have filed suit against these manufacturers, and the cases are now consolidated in Multi-District Litigation (MDL 3026) in the United States District Court for the Northern District of Illinois, before the Honorable Rebecca R. Pallmeyer. Families who lost a baby to NEC or whose infant survived with lasting harm deserve answers, accountability, and financial compensation for their loss.
View full case overview